MAPT and early-onset autosomal dominant Alzheimer disease: Nevertheless, it has recently been reported that KLK6 levels in cerebrospinal fluid (CSF) are significantly increased in patients with Alzheimer’s disease and elevated CSF phosphorylated tau (p-Tau), but not in Alzheimer’s disease patients with normal CSF p-Tau levels.